Log in
NASDAQ:ADAP

Adaptimmune Therapeutics SEC Filings & 10K Form

$4.40
-0.38 (-7.95 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.35
Now: $4.40
$4.77
50-Day Range
$4.30
MA: $7.75
$10.78
52-Week Range
$0.71
Now: $4.40
$13.40
Volume1.69 million shs
Average Volume1.91 million shs
Market Capitalization$572.48 million
P/E RatioN/A
Dividend YieldN/A
Beta2.13

SEC Filings

Adaptimmune Therapeutics (NASDAQ:ADAP) SEC Filings

DateFilerForm TypeView
10/15/2020
3:47 PM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2020
8:00 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2020
9:44 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
10:17 AM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2020
6:37 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2020
8:02 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
8:02 PM
Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
8:01 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:13 PM
Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:10 PM
Adaptimmune Therapeutics (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:09 PM
Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:09 PM
Adaptimmune Therapeutics (Issuer)
Furey John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:08 PM
Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:07 PM
Adaptimmune Therapeutics (Issuer)
Sigal Charles Elliott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:07 PM
Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:06 PM
Adaptimmune Therapeutics (Issuer)
Duncan Barbara Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
8:01 PM
Adaptimmune Therapeutics (Issuer)
Wood Gavin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
8:00 PM
Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
8:30 PM
Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
4:05 PM
Adaptimmune Therapeutics (Filer)
Form 424B5
06/02/2020
3:49 PM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2020
5:06 AM
Adaptimmune Therapeutics (Filer)
Form 424B5
05/29/2020
6:42 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
6:07 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
3:37 PM
Adaptimmune Therapeutics (Filer)
Form 10-Q/A
05/14/2020
10:02 AM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2020
6:37 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
7:06 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
7:26 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2020
7:00 AM
Adaptimmune Therapeutics (Filer)
Form DEF 14A
04/08/2020
7:06 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2020
7:00 AM
Adaptimmune Therapeutics (Filer)
Form PRE 14A
04/01/2020
6:06 PM
Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
6:06 PM
Adaptimmune Therapeutics (Issuer)
Wood Gavin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
6:05 PM
Adaptimmune Therapeutics (Issuer)
Wood Gavin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2020
10:50 AM
Adaptimmune Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2020
6:39 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
7:07 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
3:20 PM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
3:52 PM
Adaptimmune Therapeutics (Issuer)
Florence Anthony A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:52 PM
Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:51 PM
Adaptimmune Therapeutics (Issuer)
BASKETT FOREST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:31 PM
Adaptimmune Therapeutics (Filer)
Form 424B5
01/22/2020
4:30 PM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
4:21 PM
Adaptimmune Therapeutics (Filer)
Form 424B5
01/17/2020
8:48 PM
Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
8:35 PM
Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
8:33 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
8:31 PM
Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
8:30 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:03 PM
Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:03 PM
Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:02 PM
Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:02 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:01 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
7:01 PM
Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
5:17 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:02 PM
Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2020
7:42 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
6:09 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
7:01 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
7:01 PM
Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
7:00 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
10:55 AM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
6:35 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
8:30 PM
Adaptimmune Therapeutics (Issuer)
Garone Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2019
7:14 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
7:59 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
11:15 PM
Adaptimmune Therapeutics (Filer)
Form EFFECT
09/03/2019
8:00 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
12:06 PM
Adaptimmune Therapeutics (Subject)
Citibank,N.A./ADR (Filed by)
Form F-6EF
08/30/2019
11:30 AM
Adaptimmune Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/30/2019
11:26 AM
Adaptimmune Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/27/2019
7:39 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
8:00 PM
Adaptimmune Therapeutics (Issuer)
Amado Rafael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
8:03 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
8:02 PM
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2019
10:59 AM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:23 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
6:22 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
7:07 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
7:08 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2019
7:11 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
4:41 PM
Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:40 PM
Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:01 PM
Adaptimmune Therapeutics (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Furey John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Kerr Giles Francis Bertram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Sigal Charles Elliott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Duncan Barbara Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:00 PM
Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
7:00 PM
Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
7:08 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
5:00 PM
Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
7:11 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
1:57 PM
Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
7:11 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
6:38 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
6:08 AM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
3:56 PM
Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.